Overexpression of ZKSCAN3 enhances CCND2 promoter activity and induces protein expression [94], whereas gene silencing significantly reduces CCND2 levels, which in turn inhibits myeloma cell proliferation [17,63]. Here, CCND2 is linked to plasma cell myeloma.